Representation of Women and Racially and Ethnically Marginalized Principal Investigators in Vascular Device Trials

M Libby Weaver; Tara Srinivas; Sanuja Bose; Sarah E Deery; Michael Fiore Amendola; James H Black 3rd; Caitlin W Hicks

doi:10.1001/jamasurg.2023.7174

Representation of Women and Racially and Ethnically Marginalized Principal Investigators in Vascular Device Trials

JAMA Surg. 2024 Apr 1;159(4):459-461. doi: 10.1001/jamasurg.2023.7174.

Authors

M Libby Weaver¹, Tara Srinivas², Sanuja Bose³, Sarah E Deery⁴, Michael Fiore Amendola^{5

6}, James H Black 3rd³, Caitlin W Hicks³

Affiliations

¹ Division of Vascular and Endovascular Surgery, University of Virginia, Charlottesville.
² Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁴ Division of Vascular Surgery, Maine Medical Center, Portland.
⁵ Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond.
⁶ Department of Surgery, Central Virginia Veterans Affairs Health Care System, Richmond.

PMID: 38265785
PMCID: PMC10809132 (available on 2025-01-24)
DOI: 10.1001/jamasurg.2023.7174

No abstract available

Plain language summary

This quality improvement study describes the lack of diversity in trial leadership, especially in arterial disease device trials, and recommends action steps.

MeSH terms

Ethnicity*
Female
Humans
Leadership*